Secondary uses and the governance of de-identified data: Lessons from the human genome diversity panel
Open Access
- 26 September 2011
- journal article
- Published by Springer Nature in BMC Medical Ethics
- Vol. 12 (1) , 16
Abstract
Recent changes to regulatory guidance in the US and Europe have complicated oversight of secondary research by rendering most uses of de-identified data exempt from human subjects oversight. To identify the implications of such guidelines for harms to participants and communities, this paper explores the secondary uses of one de-identified DNA sample collection with limited oversight: the Human Genome Diversity Project (HGDP)-Centre d'Etude du Polymorphisme Humain, Fondation Jean Dausset (CEPH) Human Genome Diversity Panel.Keywords
This publication has 24 references indexed in Scilit:
- Data sharing in genomics — re-shaping scientific practiceNature Reviews Genetics, 2009
- Ethical aspects of genome diversity research: genome research into cultural diversity or cultural diversity in genome research?Medicine, Health Care and Philosophy, 2008
- The Human Genome Diversity Project: past, present and futureNature Reviews Genetics, 2005
- The Human Genome Diversity Project2005
- The human genome diversity projectCultural Studies, 2004
- Genetic Structure of Human PopulationsScience, 2002
- Faultlines in "Bioscience Ethics": Lessons from the Human Genome Diversity ProjectThe American Journal of Bioethics, 2002
- A Human Genome Diversity Cell Line PanelScience, 2002
- Human genome diversity: What about the other human genome project?Nature Reviews Genetics, 2001
- Call for a worldwide survey of human genetic diversity: A vanishing opportunity for the Human Genome ProjectGenomics, 1991